Publications
Showing records 21 - 40 (of 143)
Publication: JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID
Author
Year
Title
Publisher
4658545 Meyre, Pascal B; Blum, Steffen; Hennings, Elisa; Aeschbacher, Stefanie; Reichlin, Tobias; Rodondi, Nicolas; Beer, Jürg H; Stauber, Annina; Müller, Andreas; Sinnecker, Tim; Moutzouri, Elisavet; Paladini, Rebecca E; Moschovitis, Giorgio; Conte, Giulio; Auricchio, Angelo; Ramadani, Alexandra; Schwenkglenks, Matthias; Bonati, Leo H; Kühne, Michael; Osswald, Stefan; Conen, David
2022
Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing.
European heart journal
2572048 Schwenkglenks, Matthias; Gerbershagen, Hans J; Taylor, Rod S; Pogatzki-Zahn, Esther; Komann, Marcus; Rothaug, Judith; Volk, Thomas; Yahiaoui-Doktor, Maryam; Zaslansky, Ruth; Brill, Silviu; Ullrich, Kristin; Gordon, Debra B; Meissner, Winfried
2014
Correlates of satisfaction with pain treatment in the acute postoperative period : Results from the international PAIN OUT registry
Pain
4618252 Schur, Nadine; Gudala, Kapil; Vudumula, Umakanth; Vadapelle, Sreelatha; Bhadhuri, Arjun; Casanova, Alain; Adlard, Nicholas; Schwenkglenks, Matthias
2021
Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland
PharmacoEconomics
4525713 Warren, Emma; Morgan, Kristen; Toward, Toby J.; Schwenkglenks, Matthias; Leadbetter, Joanna
2019
Cost Effectiveness of Inhaled Mannitol (Bronchitol; ®; ) in Patients with Cystic Fibrosis
PharmacoEconomics
4524637 Bhadhuri, Arjun; Insinga, Ralph; Guggisberg, Patrik; Panje, Cedric; Schwenkglenks, Matthias
2019
Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland
Swiss Medical Weekly
4487592 Leon-Reyes, Selene; Schäfer, Juliane; Früh, Mathias; Schwenkglenks, Matthias; Reich, Oliver; Schmidlin, Kurt; Staehelin, Cornelia; Battegay, Manuel; Cavassini, Matthias; Hasse, Barbara; Bernasconi, Enos; Calmy, Alexandra; Hoffmann, Matthias; Schoeni-Affolter, Franziska; Zhao, Hongwei; Bucher, Heiner C.
2019
Cost estimates for HIV care and patient characteristics for health resource utilisation from linkage of claims data with the Swiss HIV Cohort Study
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
4615122 Widén, Julia; Ivarsson, Magnus; Schalin, Lovisa; Vrouchou, Polina; Schwenkglenks, Matthias; Heimbürger, Olof; Ademi, Zanfina; Sutherland, C. Simone
2020
Cost-Effectiveness Analysis of Patiromer in Combination with Renin-Angiotensin-Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden
PharmacoEconomics
4658549 Galactionova, Katya; Salari, Paola; Mattli, Renato; Rachamin, Yael; Meier, Rahel; Schwenkglenks, Matthias
2022
Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease.
PharmacoEconomics
4638642 Barbier, Michaela; Durno, Nicholas; Bennison, Craig; Örtli, Mathias; Knapp, Christian; Schwenkglenks, Matthias
2021
Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland
The European journal of health economics : HEPAC : health economics in prevention and care
4645482 Salari, Paola; O'Mahony, Cian; Henrard, Séverine; Welsing, Paco; Bhadhuri, Arjun; Schur, Nadine; Roumet, Marie; Beglinger, Shanthi; Beck, Thomas; Jungo, Katharina; Byrne, Stephen; Hossmann, Stefanie; Knol, Wilma; O'Mahony, Denis; Spinewine, Anne; Rodondi, Nicolas; Schwenkglenks, Matthias
2022
Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study
PLoS One
1194539 Fox, Keith A. A.
2011
Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes
Value in health
4487604 Aichmair, Alexander; Burgstaller, Jakob M.; Schwenkglenks, Matthias; Steurer, Johann; Porchet, François; Brunner, Florian; Farshad, Mazda; Lsos Study Group,
2017
Cost-effectiveness of conservative versus surgical treatment strategies of lumbar spinal stenosis in the Swiss setting: analysis of the prospective multicenter Lumbar Stenosis Outcome Study (LSOS)
European spine journal
4487590 Schur, Nadine; Brugaletta, Salvatore; Cequier, Angel; Iñiguez, Andrés; Serra, Antonio; Jiménez-Quevedo, Pilar; Mainar, Vicente; Campo, Gianluca; Tespili, Maurizio; den Heijer, Peter; Bethencourt, Armando; Vazquez, Nicolás; Valgimigli, Marco; Serruys, Patrick W.; Ademi, Zanfina; Schwenkglenks, Matthias; Sabaté, Manel
2018
Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial
PloS one
4487601 Tomonaga, Yuki; Ten Haaf, Kevin; Frauenfelder, Thomas; Kohler, Malcolm; Kouyos, Roger D.; Shilaih, Mohaned; Lorez, Matthias; de Koning, Harry J.; Schwenkglenks, Matthias; Puhan, Milo A.
2018
Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study
Lung cancer (Amsterdam, Netherlands)
1196858 Matter-Walstra, Klazien; Joerger, Markus; Kühnel, Ursula; Szucs, Thomas; Pestalozzi, Bernhard; Schwenkglenks, Matthias
2012
Cost-effectiveness of maintenance pemetrexed in patients with advanced nonsquamous-cell lung cancer from the perspective of the swiss health care system
Value in health
4525714 Hirschmann, A.; Lupatsch, J. E.; Schwenkglenks, M.; Panje, C. M.; Matter-Walstra, K.; Espeli, V.; Dedes, K. J.; Siano, M.
2018
Cost-effectiveness of nivolumab in the treatment of head and neck cancer
Oral oncology
4658547 Galactionova, Katya; Loibl, Sibylle; Salari, Paola; Marmé, Frederik; Martin, Miguel; Untch, Michael; Bonnefoi, Hervé R; Kim, Sung-Bae; Bear, Harry D; McCarthy, Nicole; Gelmon, Karen A; García-Sáenz, José A; Kelly, Catherine M; Reimer, Toralf; Toi, Masakazu; Rugo, Hope S; Gnant, Michael; Makris, Andreas; Burchardi, Nicole; Schwenkglenks, Matthias
2022
Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial.
Frontiers in oncology
4638650 Gubler-Gut, Barbara E.; Pöhlmann, Johannes; Flatz, Aline; Schwenkglenks, Matthias; Rohrmann, Sabine
2021
Cost-effectiveness of physical activity interventions in cancer survivors of developed countries: a systematic review
Journal of cancer survivorship : research and practice
4055376 Ademi, Zanfina; Pfeil, Alena M.; Hancock, Elizabeth; Trueman, David; Haroun, Rola Haroun; Deschaseaux, Celine; Schwenkglenks, Matthias
2017
Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction
Swiss medical weekly
4645456 Bhadhuri, Arjun; Dröschel, Daniel; Guldimann, Mike; Jetschgo, Claudia; Banhazi, Judit; Schwenkglenks, Matthias; Sutherland, C. Simone
2022
Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland
BMC Health Services Research
Showing records 21 - 40 (of 143)
